Urinary Pain Relief Tablets

Manufacturer
KROGER COMPANY
Effective date
2023-01-09
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-05-31 23:53:15

Label at a glance#

ProductUrinary Pain Relief
Active ingredientPHENAZOPYRIDINE HYDROCHLORIDE
Label structure11 sections

Indications and uses

Relief from urinary pain, burning, urgency and frequency associated with urinary tract infections. Treatment should not exceed 2 days; see Directions

Dosage and administration

Adults and children 12 years and over: Take 2 tablets 3 times daily with or after meals as needed for up to two days. Take with a full glass of water. Do not use for more than 2 days (12 tablets) without consulting a doctor Children under 12 years: Do not use without consulting a doctor

Storage and handling

This product can interfere with laboratory tests including urine, glucose (sugar), and ketones tests This product may stain contact lenses and other items if handled after touching tablets. Store at room temperature between 15°C -30°C (59°F -86°F) in a dry place and protect from light.

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

Active ingredient (in each tablet)

OTC - ACTIVE INGREDIENT SECTION

Phenazopyridine Hydrochloride 95 mg

Purpose

OTC - PURPOSE SECTION

Urinary tract analgesic

Uses

INDICATIONS & USAGE SECTION

Relief from urinary pain, burning, urgency and frequency associated with urinary tract infections. Treatment should not exceed 2 days; see Directions

Warnings

WARNINGS SECTION

Do not exceed recommended dosage

OTC - DO NOT USE SECTION

Do not use if you have Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency unless approved by your physician.

Ask a doctor before use if you have

OTC - ASK DOCTOR SECTION

  • kidney disease
  • allergies to foods, preservatives or dyes
  • had a hypersensitive reaction to Phenazopyridine

When using this product

OTC - WHEN USING SECTION

  • stomach upset may occur, taking this product with or after meals may reduce stomach upset
  • your urine will become reddish-orange in color. This is not harmful, but care should be taken to avoid staining clothing or other items.

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • your symptoms last for more than 2 days
  • you suspect you are having an adverse reaction to the medication
  • long-term administration of Phenazopyridine HCl has induced neoplasia in rats (large intestine) and mice (liver). Although no association between Phenazopyridine HCl and human neoplasia has been reported, adequate epidemiological studies along these lines have not been conducted.

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breastfeeding, ask a health professional before use.A pregnancy test and consultation with a health professional if pregnancy is confirmed is recommended prior to use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. In case of an overdose, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • Adults and children 12 years and over: Take 2 tablets 3 times daily with or after meals as needed for up to two days. Take with a full glass of water. Do not use for more than 2 days (12 tablets) without consulting a doctor
  • Children under 12 years: Do not use without consulting a doctor

Other information

STORAGE AND HANDLING SECTION

  • This product can interfere with laboratory tests including urine, glucose (sugar), and ketones tests
  • This product may stain contact lenses and other items if handled after touching tablets.
  • Store at room temperature between 15°C -30°C (59°F -86°F) in a dry place and protect from light.

Inactive ingredients

INACTIVE INGREDIENT SECTION

colloidal silicone dioxide, gum acacia extra pure, hydroxy propyl methyl cellulose, lactose monohydrate, magnesium stearate, maize starch, polyethylene glycol, povidone, pregelatinized starch, propylene glycol, sodium starch glycolate

Questions or comments?

OTC - QUESTIONS SECTION

call 1-800-632-6900

SPL UNCLASSIFIED SECTION

DISTRIBUTED BY THE KROGER CO.
CINCINNATI, OHIO 45202

PRINCIPAL DISPLAY PANEL - 95 mg Tablet Blister Pack Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

*Compare to active ingredient of AZO® URINARY
PAIN RELIEF MAXIMUM STRENGTH *see back panel
NDC XXXXX-XXX-XX

Urinary
Pain Relief

Phenazopyridine
Hydrochloride 95 mg

FAST RELIEF
FOR URINARY
DISCONFORT

actual
size

30 TABLETS

PRINCIPAL DISPLAY PANEL - 95 mg Tablet Blister Pack Carton
PRINCIPAL DISPLAY PANEL - 95 mg Tablet Blister Pack Carton

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1094126phenazopyridine HCl 95 MG Oral TabletPSN2
1094126phenazopyridine hydrochloride 95 MG Oral TabletSCD2
1094126phenazopyridine HCl 95 MG Oral TabletSY2

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
30142-757-30Urinary Pain Relief30 in 1 BLISTER PACKTABLET302
30142-757-30Urinary Pain Relief1 in 1 CARTONTABLET12

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
30142-757URINARY PAIN RELIEF (PHENAZOPYRIDINE HYDROCHLORIDE) TABLET [KROGER COMPANY]2Legacy NDC, 2 package rows20230115_6bf45f75-5a61-4f24-8468-741c945e71e5.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 12 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
30142-75730142-757-30

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 10 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
541a46f7-147c-49d1-be1c-0c64f650728a6bf45f75-5a61-4f24-8468-741c945e71e52023-01-09WarningsExact identifier
spl id: 541a46f7-147c-49d1-be1c-0c64f650728a
spl set id: 6bf45f75-5a61-4f24-8468-741c945e71e5

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.